• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘦型与肥胖型多囊卵巢综合征女性的临床代谢特征

Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women.

作者信息

Makhija Nidhi, Tayade Surekha, Toshniwal Shikha, Tilva Hard

机构信息

Department of Obstetrics and Gynaecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

出版信息

Cureus. 2023 Apr 19;15(4):e37809. doi: 10.7759/cureus.37809. eCollection 2023 Apr.

DOI:10.7759/cureus.37809
PMID:37214034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10196695/
Abstract

Background Polycystic ovarian syndrome (PCOS), which affects women of reproductive age, is the most prevalent endocrine disorder. Signs of excessive androgen, irregular menses, prolonged anovulation, and infertility are characteristics of the clinical phenotype. Women with PCOS are more likely to have diabetes, obesity, dyslipidemia, hypertension, anxiety, and depression. PCOS affects women's health starting before conception and continuing through their post-menopausal years. Methods Ninety-six study subjects were recruited from women visiting the gynaecology clinic according to the Rotterdam criteria for PCOS. Study subjects were then divided into lean and obese groups according to their body mass index (BMI). Demographic data, and obstetrical and gynaecological history were obtained including marital status, menstrual cycle regularity, recent abnormal weight gain (in the preceding six months), and subfertility. To identify any clinical signs of hyperandrogenism such as acne, acanthosis nigricans, or hirsutism, a general and systemic examination was conducted. Data were analyzed after the clinico-metabolic profile was assessed, compared, and contrasted between the two groups. Results The findings showed a significant correlation between obese women with PCOS and the clinical profile of PCOS i.e. menstrual irregularities, acne vulgaris, acanthosis nigricans and hirsutism; the waist-hip ratio was higher in both groups. Higher levels of fasting insulin, fasting glucose: insulin ratio, postprandial sugars, homeostasis model assessment of insulin resistance (HOMA-IR) index, total testosterone, free testosterone, and luteinizing hormone/follicle-stimulating hormone (LH: FSH) ratio were seen in obese women with PCOS, whereas the levels of fasting glucose, serum triglycerides, serum high-density lipoprotein cholesterol (HDL) were higher in all the study subjects irrespective of BMI. Conclusion The study showed that women with PCOS have a deranged metabolic profile like abnormal blood sugar, insulin resistance (IR), and hyperandrogenemia with clinical derangements like irregular menses, subfertility, and recent weight gain more frequently with higher BMI.

摘要

背景

多囊卵巢综合征(PCOS)影响育龄女性,是最常见的内分泌紊乱疾病。雄激素过多、月经不规律、长期无排卵和不孕是其临床表型的特征。患有PCOS的女性更易患糖尿病、肥胖、血脂异常、高血压、焦虑和抑郁。PCOS在受孕前就开始影响女性健康,并持续到绝经后。方法:根据鹿特丹PCOS诊断标准,从妇科门诊就诊的女性中招募了96名研究对象。然后根据体重指数(BMI)将研究对象分为瘦型和肥胖型两组。收集人口统计学数据以及妇产科病史,包括婚姻状况、月经周期规律、近期体重异常增加(前六个月内)和生育力低下情况。为了识别高雄激素血症的任何临床体征,如痤疮、黑棘皮病或多毛症,进行了全身检查。在评估、比较和对比两组的临床代谢特征后对数据进行分析。结果:研究结果显示,肥胖型PCOS女性与PCOS的临床特征之间存在显著相关性,即月经不规律、寻常痤疮、黑棘皮病和多毛症;两组的腰臀比均较高。肥胖型PCOS女性的空腹胰岛素水平、空腹血糖:胰岛素比值、餐后血糖、胰岛素抵抗稳态模型评估(HOMA-IR)指数、总睾酮、游离睾酮和黄体生成素/促卵泡激素(LH:FSH)比值较高,而无论BMI如何,所有研究对象的空腹血糖、血清甘油三酯、血清高密度脂蛋白胆固醇(HDL)水平均较高。结论:该研究表明,PCOS女性存在代谢紊乱,如血糖异常、胰岛素抵抗(IR)和高雄激素血症,且临床紊乱如月经不规律、生育力低下和近期体重增加在BMI较高的情况下更为常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5748/10196695/fbdc695466ad/cureus-0015-00000037809-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5748/10196695/fbdc695466ad/cureus-0015-00000037809-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5748/10196695/fbdc695466ad/cureus-0015-00000037809-i01.jpg

相似文献

1
Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women.瘦型与肥胖型多囊卵巢综合征女性的临床代谢特征
Cureus. 2023 Apr 19;15(4):e37809. doi: 10.7759/cureus.37809. eCollection 2023 Apr.
2
[Exploration of the classification of polycystic ovarian syndrome].[多囊卵巢综合征的分类探索]
Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8.
3
[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].肥胖型多囊卵巢综合征肥胖女性的临床特征、激素谱及代谢异常
Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71.
4
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
5
Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.中国多囊卵巢综合征女性的临床特征、代谢特征和表型:一项大规模病例对照研究。
Arch Gynecol Obstet. 2013 Mar;287(3):525-31. doi: 10.1007/s00404-012-2568-z. Epub 2012 Oct 30.
6
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.基于鹿特丹标准的多囊卵巢综合征病例与仅有少排卵/无排卵或多毛症等临床体征的女性的临床和实验室特征比较。
Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12.
7
Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.二甲双胍治疗对多囊卵巢综合征女性高雄激素血症的影响。
Gynecol Endocrinol. 2003 Feb;17(1):51-6.
8
Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index.多囊卵巢综合征:肥胖是必要条件吗?一项与体重指数相关的临床、激素及代谢评估
Indian J Endocrinol Metab. 2012 Nov;16(6):996-9. doi: 10.4103/2230-8210.103011.
9
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南 - 第2部分。
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
10
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.多囊卵巢综合征女性的皮肤表现及全身相关情况。
JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498.

引用本文的文献

1
Global hotspots and trends in Acanthosis nigricans research: A bibliometric and visualized analysis.全球黑棘皮病研究的热点和趋势:文献计量学和可视化分析。
Skin Res Technol. 2024 Sep;30(9):e70054. doi: 10.1111/srt.70054.
2
Understanding metabolic patterns in polycystic ovary syndrome: Comparing lean and obese women at a family medicine clinic.了解多囊卵巢综合征的代谢模式:在一家家庭医学诊所对体重正常和肥胖女性进行比较。
J Family Med Prim Care. 2024 May;13(5):1837-1842. doi: 10.4103/jfmpc.jfmpc_1425_23. Epub 2024 May 24.
3
Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations.

本文引用的文献

1
Nesfatin-1, Dopamine, and NADPH levels in Infertile Women with Polycystic Ovary Syndrome: Is There a Relationship Between Their Levels and Metabolic and Hormonal Variables.多囊卵巢综合征不孕女性中Nesfatin-1、多巴胺和NADPH水平:它们的水平与代谢及激素变量之间存在关联吗?
J Reprod Infertil. 2022 Jul-Sep;23(3):160-168. doi: 10.18502/jri.v23i3.10006.
2
Expression of Serum PSA, Nesfatin-1, and AMH in Patients with Polycystic Ovary Syndrome.多囊卵巢综合征患者血清 PSA、nesfatin-1 和 AMH 的表达。
Cell Mol Biol (Noisy-le-grand). 2022 Feb 4;67(5):57-63. doi: 10.14715/cmb/2021.67.5.8.
3
Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.
多囊卵巢综合征女性的食物渴望和肥胖:病理生理和治疗考虑。
Nutrients. 2024 Apr 3;16(7):1049. doi: 10.3390/nu16071049.
4
Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study.LHCGR 多态性在多囊卵巢综合征中的意义:一项关联研究。
Sci Rep. 2023 Dec 21;13(1):22841. doi: 10.1038/s41598-023-48881-0.
多囊卵巢综合征患者新型潜在胰岛素抵抗生物标志物的研究进展——争议仍未解决。
Int J Environ Res Public Health. 2022 Feb 13;19(4):2099. doi: 10.3390/ijerph19042099.
4
Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center.三级护理中心多囊卵巢综合征患者的皮肤表现和激素变化
Cureus. 2021 Dec 22;13(12):e20593. doi: 10.7759/cureus.20593. eCollection 2021 Dec.
5
DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study.多囊卵巢综合征中DLK1和Nesfatin-1水平及其与代谢参数的关系:前瞻性对照研究
Turk J Obstet Gynecol. 2021 Jun 2;18(2):124-130. doi: 10.4274/tjod.galenos.2021.39024.
6
The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review.多囊卵巢综合征的患病率:一项简要的系统评价。
J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-271. doi: 10.4103/jhrs.JHRS_95_18. Epub 2020 Dec 28.
7
Copeptin and Nesfatin-1 Are Interrelated Biomarkers with Roles in the Pathogenesis of Insulin Resistance in Chinese Children with Obesity. copeptin 和 nesfatin-1 是相关的生物标志物,在肥胖中国儿童胰岛素抵抗的发病机制中发挥作用。
Ann Nutr Metab. 2020;76(4):223-232. doi: 10.1159/000508883. Epub 2020 Oct 7.
8
Elevated and diagnostic androgens of polycystic ovary syndrome.多囊卵巢综合征升高的诊断性雄激素
Prz Menopauzalny. 2020 Mar;19(1):1-5. doi: 10.5114/pm.2020.95293. Epub 2020 Apr 27.
9
Women with Polycystic Ovary Syndrome: A Marginalized Population in the United States.患有多囊卵巢综合征的女性:美国的一个边缘化群体。
Health Soc Work. 2020 Jan 7;45(1):40-46. doi: 10.1093/hsw/hlz033.
10
Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.印度多囊卵巢综合征的流行病学、发病机制、遗传学和管理。
Indian J Med Res. 2019 Oct;150(4):333-344. doi: 10.4103/ijmr.IJMR_1937_17.